Clearmind Medicine, Inc. (CMND)
2.26
-0.20
(-8.13%)
USD |
NASDAQ |
May 22, 16:00
2.25
-0.01
(-0.44%)
After-Hours: 20:00
Clearmind Medicine EPS Diluted (Quarterly) : -3.317 for Jan. 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CannaPharmaRx, Inc. | -0.0006 |
| Pharmagreen Biotech, Inc. | -0.0017 |
| Lexaria Bioscience Corp. | -0.0593 |
| InMed Pharmaceuticals, Inc. | -0.7327 |
| Target Group, Inc. (Canada) | -0.0009 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.855M |
| Total Expenses (Quarterly) | 3.855M |
| Enterprise Value | -8.036M |
| Earnings Yield | -799.6% |
| Normalized Earnings Yield | -971.53 |